<DOC>
	<DOC>NCT00428792</DOC>
	<brief_summary>This study evaluated the safety and clinical effect of treatment with methylphenidate under different breakfast conditions (minimal breakfast versus standard continental breakfast) in children with Attention-Deficit Hyperactivity Disorder (ADHD).</brief_summary>
	<brief_title>Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Children aged 612 Diagnosis of AttentionDeficit Hyperactivity Disorder (ADHD) Current medication with either 20 mg or 40 mg immediate release methylphenidate Concomitant psychiatric disorders requiring pharmacological treatment Concomitant severe somatic disorders Eating disorders Addiction disorders Very high or low body weight according to age Known hypersensitivity to methylphenidate Contraindications for methylphenidate Other protocoldefined inclusion/exclusion criteria applied to the study.</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>ADHD</keyword>
	<keyword>methylphenidate</keyword>
	<keyword>children</keyword>
	<keyword>food effect</keyword>
	<keyword>Attention-Deficit Hyperactivity Disorder (ADHD) in children</keyword>
</DOC>